Supernus Pharmaceuticals, Inc. (SUPN)
43.74
-0.47
(-1.06%)
USD |
NASDAQ |
Sep 01, 16:00
43.76
+0.02
(+0.05%)
After-Hours: 20:00
Supernus Pharmaceuticals Net Income (TTM) : -109.89M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -109.89M |
| March 31, 2026 | -29.02M |
| December 31, 2025 | -38.55M |
| September 30, 2025 | -19.12M |
| June 30, 2025 | 64.50M |
| March 31, 2025 | 61.91M |
| December 31, 2024 | 73.86M |
| September 30, 2024 | 59.71M |
| June 30, 2024 | 5.239M |
| March 31, 2024 | -15.51M |
| December 31, 2023 | 1.316M |
| September 30, 2023 | 25.62M |
| June 30, 2023 | 43.35M |
| March 31, 2023 | 52.04M |
| December 31, 2022 | 60.71M |
| September 30, 2022 | 37.67M |
| June 30, 2022 | 57.48M |
| March 31, 2022 | 73.35M |
| December 31, 2021 | 53.42M |
| September 30, 2021 | 81.75M |
| June 30, 2021 | 100.18M |
| March 31, 2021 | 111.13M |
| December 31, 2020 | 126.95M |
| September 30, 2020 | 129.31M |
| June 30, 2020 | 118.17M |
| Date | Value |
|---|---|
| March 31, 2020 | 116.23M |
| December 31, 2019 | 113.06M |
| September 30, 2019 | 105.82M |
| June 30, 2019 | 104.97M |
| March 31, 2019 | 102.98M |
| December 31, 2018 | 110.99M |
| September 30, 2018 | 98.76M |
| June 30, 2018 | 86.71M |
| March 31, 2018 | 73.34M |
| December 31, 2017 | 57.28M |
| September 30, 2017 | 57.95M |
| June 30, 2017 | 103.81M |
| March 31, 2017 | 96.69M |
| December 31, 2016 | 91.22M |
| September 30, 2016 | 83.75M |
| June 30, 2016 | 26.15M |
| March 31, 2016 | 18.34M |
| December 31, 2015 | 14.25M |
| September 30, 2015 | 11.75M |
| June 30, 2015 | 35.39M |
| March 31, 2015 | 36.15M |
| December 31, 2014 | 19.87M |
| September 30, 2014 | -6.889M |
| June 30, 2014 | -58.84M |
| March 31, 2014 | -89.40M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Indivior Pharmaceuticals, Inc. | 355.00M |
| Pfizer Inc. | 4.373B |
| Amphastar Pharmaceuticals, Inc. | 78.55M |
| Collegium Pharmaceutical, Inc. | 47.92M |
| Bristol Myers Squibb Co. | 9.275B |